RISK BASED INSPECTION [SCHEDULE M-POINT (8.13-8.15)]
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.13-8.15)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.13-8.15-768x1086.jpg)
Risk-Based Inspection (RBI) is a GMP approach where inspectors decide the frequency, depth and breadth of inspection using Quality Risk Management, focusing more effort on systems that can most impact patient safety and product quality. CDSCO In the RBI checklist,…





![RISK BASED INSPECTION [SCHEDULE M-POINT (8.10-8.12)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.10-8.12-1-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.9)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.9-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.8)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.8-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.7)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.7-768x1086.jpg)




